A Review of Ruxolitinib for the Treatment of Myelofibrosis: A Critique of the Evidence.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2017 AND VI 35 AND IP 2
Results: 10
1
2
Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
- Published in:
- 2017
- By:
- Publication type:
- journal article
3
Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
4
Emergent Challenges in Determining Costs for Economic Evaluations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
5
Simulation Modelling in Ophthalmology: Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom.
- Published in:
- 2017
- By:
- Publication type:
- journal article
6
Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
7
Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
8
Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.
- Published in:
- 2017
- By:
- Publication type:
- journal article
9
A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010-2016.
- Published in:
- 2017
- By:
- Publication type:
- journal article
10
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article